MHRA Drug Safety Update March 2022
Links to the MHRA Drug Safety Update for March 2022 are listed below.
- Cladribine (Mavenclad): new advice to minimise risk of serious liver injury
- Amiodarone (Cordarone X): reminder of risks of treatment and need for patient monitoring and supervision
- Metformin in pregnancy: study shows no safety concerns
- COVID-19 vaccines and medicines: updates for March 2022
- Letters and medicine recalls sent to healthcare professionals in February 2022
You can sign up to receive these alerts directly from the MHRA at: MHRA email alerts
Published 01/04/2022. Medicines Update blogs are correct at the time of publication.
We would like to hear what you think of Medicines Update blogs. Please leave us your feedback using this anonymous survey here.